Aptus Capital Advisors, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1664193
FAIRHOPE, AL
Position in VRTX
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$6,539,131
-$915,014 QoQ
Shares Held
14,644
-10.9% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 86.55422015842666.ToString("F0")%
Shared 0.ToString("F0")%
None 13.44577984157334.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Aptus Capital Advisors, LLC holds $15,216,864 across 16 Biotechnology names. VRTX ranks #1 (43.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
14,644 | $6,539,131 | |
| 2 | OCUL |
Ocular Therapeutix, Inc
|
529,779 | $4,487,228 | |
| 3 | RPRX |
Royalty Pharma plc
|
21,335 | $1,023,439 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,264 | $976,616 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,513 | $500,606 | |
| 6 | MIST |
Milestone Pharmaceuticals Inc.
|
280,250 | $333,497 | |
| 7 | INCY |
Incyte Corp
|
2,794 | $262,971 | |
| 8 | EXEL |
Exelixis, Inc.
|
5,950 | $255,195 |
All Filings in VRTX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,539,131 | 14,644 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $7,454,145 | 16,442 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $6,170,288 | 15,755 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $6,182,492 | 13,887 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $11,752,036 | 24,240 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $8,927,053 | 22,168 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $8,704,437 | 18,716 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $7,333,124 | 15,645 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $5,158,243 | 12,340 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $701,885 | 1,725 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $616,195 | 1,772 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $377,951 | 1,074 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $325,467 | 1,033 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $394,473 | 1,366 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $362,214 | 1,251 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $287,989 | 1,022 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $270,103 | 1,035 | Shares | Sole | 2022-05-04 | |
| No filing history on record for this holder in this stock. | ||||||